Prevention and treatment of osteoporosis in postmenopausal women - Clinical Update

Journal of Family Practice, Oct, 2002 by Linda French, Mindy Smith, Leslie Shimp

REFERENCES

(1.) Osteoporosis Prevention, Diagnosis, and Therapy. NIH Consensus Statement Online 2000 March 27-29; [cited 9/2/2]; 17(1):1-36.

(2.) World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: World Health Organization; 1994.

(3.) NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285:785-795.

(4.) Gold DT. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone. 1996; 18(suppl 3):185S-189S.

(5.) Black DM, Arden NK, Palermo I, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999; 14:821-828.

(6.) Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997; 12:24-35.

(7.) Looker AC, Wahner HW, Dunn WL, et al. Updated data on proximal femur hone mineral levels of US adults. Osteoporos Int. 1998; 8:468-489.

(8.) Aloia JF, Vaswani A, Yeh JK, Flaster E. Risk for osteoporosis in black women. Calcif Tissue Int. 1996; 59:415-423.

(9.) Melton LJ. How many women have osteoporosis now? J Bone Miner Res. 1995; 10:175-177.

(10.) Nelson HD, Morris CD, Mahon S, Carney N, Nygren PM, Helfand M. Osteoporosis in postmenopausal women: diagnosis and monitoring. Evidence Report/Technology Assessment Number 28. Rockville, MD: Agency for Healthcare Research and Quality; November 2001. 01-E032.

(11.).Melton LJ 3rd, Amadio PC, Crowson CS, O'Fallon WM. Long term trends in the incidence of distal forearm fractures. Osteoporos Int. 1998;8:341-348.

(12.) National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int. 1998; 8(suppl):S7-S80.

(13.) U.S. Preventive Services Task Force. Screening for Osteoporosis in Postmenopausal Women. September 2002. Originally in Annals of Internal Medicine 2002;137:526-8. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/osteoporosis/osteorr.htm.> (14.) Physician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 1998.

(15.) American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of osteoporosis. Endocr Pract. 2001; 7:293-312.

(16.) North American Menopause Society. Management of postmenopausal osteoporosis: position statement of The North American Menopause Society. Menopause. 2002; 9:84-101.

(17.) Cadarette SM, Jaglal SB, Murray TM, McIsaac WJ, Joseph L, Brown JP. Evaluation of decision rules for referring women for hone densitometry by dual energy x-ray absorptiometry. JAMA. 2001; 286:57-63.